Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Edwards Lifesciences (NY: EW )

66.47 -1.07 (-1.58%)
Official Closing Price Updated: 7:00 PM EST, Nov 4, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Edwards Lifesciences

< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Nasdaq Gains 1%; American Airlines Cuts Earnings Forecast
Via Benzinga
Stocks Bouncing Back After Data Hints At 'Soft Landing'
Stocks are on the move midday, as Wall Street weighs an upbeat second-quarter gross domestic product (GDP) reading with the recent tech sector selloff. 
Via Talk Markets
Stocks Rebound As US Economy Flexes Muscles, Small Caps Rally, Gold Falls: What's Driving Markets Thursday?
Wall Street strongly rebounded Thursday after Wednesday’s slump, driven by stronger-than-expected economic growth in the last quarter, countering concerns of a slowdown. 
Via Benzinga
Topics Economy
Exposures Economy
P/E Ratio Insights for Edwards Lifesciences
Via Benzinga
$1000 Invested In This Stock 20 Years Ago Would Be Worth $33,000 Today
Via Benzinga
This Lululemon Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday
Via Benzinga
Ford Posts Downbeat Earnings, Joins MaxLinear, STMicroelectronics And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
Via Benzinga
Viking Therapeutics (VKTX) Stock Pops on Plans to Start Late-Stage Weight Loss Drug Trials
Viking Therapeutics stock is up on Thursday as VKTX investors react to the company preparing for a Phase 3 trial of its weight loss drug. 
Via InvestorPlace
LINE Stock: 7 Things to Know as Lineage Starts Trading Today
Lineage stock is going to start trading later today and we have all of the details investors need to know about LINE shares on Thursday. 
Via InvestorPlace
Why Is Edwards Lifesciences (EW) Stock Down 22% Today?
Edwards Lifesciences stock is down on Thursday as EW investors digest the company's latest earnings report and outlook this morning. 
Via InvestorPlace
The Analyst Landscape: 13 Takes On Edwards Lifesciences
Via Benzinga
Peering Into Edwards Lifesciences's Recent Short Interest
Via Benzinga
$100 Invested In Edwards Lifesciences 20 Years Ago Would Be Worth This Much Today
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Pre-market stock movers are a hot topic on Thursday morning and we have all of the latest news traders need to know about them! 
Via InvestorPlace
Nasdaq, S&P Futures Slide On More Negative Tech Tidings As Focus Shifts To Q2 GDP Data: Strategist Says Trump Trades May Not Work Even If Ex-President Retakes White House
Sentiment continues to be jittery, with the major index futures priming for a lower opening on Thursday as traders look ahead to the first read of second-quarter GDP data and more earnings. The tech... 
Via Benzinga
Topics Government Stocks
Exposures Political US Equities
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Via Benzinga
EW Stock Earnings: Edwards Lifesciences Beats EPS, Misses Revenue for Q2 2024
EW stock results show that Edwards Lifesciences beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024. 
Via InvestorPlace
Edwards Stock Plummets After Medtech Slashes Its TAVR Outlook For The Year
The company now expects full-year sales in its TAVR division to climb 5% to 7%. 
Via Investor's Business Daily
Edwards Lifesciences Expands Structural Heart Portfolio With Acquisitions of JenaValve and Endotronix
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences Reports Second Quarter Results
From Edwards Lifesciences Corporation
Via Business Wire
US Stocks Tumble, Magnificent 7 Wipe Out $570 Billion As Mega-Tech Earnings Disappoint, VIX Spikes: What's Driving Markets Wednesday?
Wall Street experienced a turbulent session on Wednesday, with the S&P 500 index heading toward its worst performance in over a year and the tech-focused Nasdaq 100 eyeing its fifth decline in the last... 
Via Benzinga
Topics Stocks
Exposures US Equities
US Stocks Could Open Sharply Lower As Tesla, Alphabet Earnings Offer No Cheer: Analyst Says This Bodes Well For Small-Caps, 'Only Takes A Small Spark To Ignite A Powerful Move'
Wall Street is gearing up for a negative start on Thursday, as traders mull over earnings from Tesla, Inc. (NASDAQ:TSLA) and Alphabet, Inc. 
Via Benzinga
Tesla, Alphabet, GM, Ford Lead Earnings Parade This Week As Market Struggles To Sustain The Summer Rally
The earnings parade continues this week with a slightly accelerated tempo as analysts brace for a healthy reporting season. 
Via Benzinga
Edwards Lifesciences to Host Earnings Conference Call on July 24, 2024
From Edwards Lifesciences Corporation
Via Business Wire
Edwards Lifesciences to Acquire Innovalve
From Edwards Lifesciences Corporation
Via Business Wire
UnitedHealth, Edwards Lifesciences, First Citizens Bank And More: CNBC's 'Final Trades'
UnitedHealth Group was declared a "solid" healthcare company on CNBC. Cantor Fitzgerald analyst Sarah James maintains a price target of $591. 
Via Benzinga
Stock Market Revs To Highs On Nvidia, CrowdStrike, Yields: Weekly Review
The Nasdaq and S&P 500 hit record highs, but small caps retreated. 
Via Investor's Business Daily
Topics Stocks
Exposures US Equities
Five-Year Data Show Excellent Outcomes for Female and Small Annulus Patients With Edwards TAVR
From Edwards Lifesciences Corporation
Via Business Wire
BD Bolsters Portfolio With $4.2B Cash Deal For Edwards Lifesciences' Critical Care Group: Details
BD (Becton, Dickinson and Company) will acquire Edwards Lifesciences' Critical Care product group for $4.2 billion in cash. This acquisition enhances BD's portfolio with advanced AI-enabled monitoring... 
Via Benzinga
Edwards Lifesciences Stock Nears Breakout On A Surprise $4.2 Billion Deal
Edwards Lifesciences stock rallied Monday on medtech giant Becton Dickinson's plan to buy a key division for $4.2 billion. 
Via Investor's Business Daily
< Previous 1 2 3 4 5 6 7 8 9
...
14 15 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.